Intelligent Bio Solutions Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Net Income	-10.03	-10.63	-8.31	-7.04	-3.16	-7.34
Depreciation & Amortization	1.1	0.97	0	0	0	0
Share-Based Compensation	0.22	0.26	0	0	0	0
Other Operating Activities	1.51	2.03	4.95	-4.26	2.67	1.76
Operating Cash Flow	-7.21	-7.38	-3.36	-11.3	-0.5	-5.58
Capital Expenditures	-0.56	-0.51	-0.38	0	0	0
Acquisitions	-0.18	-0.19	0	0	-0.01	0
Other Investing Activities	0.51	-	-0.5	-	-	-
Investing Cash Flow	-0.24	-0.69	-0.88	0	-0.01	0
Share Issuance / Repurchase	13.75	2.04	0	20.11	-0.12	-0.38
Debt Issued / Paid	0.1	0	0	0	-0.15	0
Other Financing Activities	-3.04	-0.6	-	3.29	1	5.7
Financing Cash Flow	10.82	1.44	0	23.4	0.73	5.32
Exchange Rate Effect	-0.04	-0.06	-0.1	0.04	0.01	0.04
Net Cash Flow	7.12	-6.7	-4.34	12.15	0.23	-0.22
Free Cash Flow	-7.77	-7.88	-3.74	-11.3	-0.5	-5.58
Free Cash Flow Margin	-241.86%	-395.21%	-855.15%	-570.39%	-264.18%	-2966587.23%
Free Cash Flow Per Share	-3.74	-94.16	-61.18	-260.31	-14.06	-159.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).